Genomic Valley Biotech

Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the...

03 Apr, 2026 | 01:01pm • Source: BSE

Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the...

01 Apr, 2026 | 04:28pm • Source: BSE

Closure of Trading Window for the quarter and year ending on March 31, 2026.

24 Mar, 2026 | 03:38pm • Source: BSE

Please find enclosed herewith unaudited financial results for the quarter and nine months ended on 31st December 2025.

17 Jan, 2026 | 12:14pm • Source: BSE

Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 for the quarter ended on 31st December, 2025.

06 Jan, 2026 | 05:48pm • Source: BSE

Submission of voting results of 31st Annual General Meeting of the Company under Regulation 44(3) of the SEBI (listing Obligations & Disclosure Requirements) Regulations, 2015.

01 Jan, 2026 | 03:58pm • Source: BSE

Please find enclosed herewith copy of proceeding of 31st Annual General Meeting of the company for your reference.

31 Dec, 2025 | 09:52am • Source: BSE

Please find enclosed herewith intimation of closure of trading window.

29 Dec, 2025 | 02:13pm • Source: BSE

Please find enclosed herewith Newspaper intimation for the 31st Annual General Meeting for your reference.

10 Dec, 2025 | 12:18pm • Source: BSE

Please find enclosed herewith the Notice of the Annual General Meeting for your reference.

09 Dec, 2025 | 03:52pm • Source: BSE

Compliance Under Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Annual Report for The Financial Year 2024-25

09 Dec, 2025 | 03:42pm • Source: BSE

Please find enclosed herewith book closure intimation for your reference.

08 Dec, 2025 | 05:28pm • Source: BSE

Please Find enclosed herewith the Outcome of the Board Meeting dated 08/12/2025 for your reference.

08 Dec, 2025 | 05:16pm • Source: BSE

Please find enclosed herewith un-audiited financial results for the quarter and half year ended on 30th September 2025.

17 Oct, 2025 | 12:00pm • Source: BSE

Please find enclosed herewith unaudited standalone financial results for the Quarter and half Yearly ended on September 30th, 2025.

15 Oct, 2025 | 03:34pm • Source: BSE

Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation ,2015 held on today i.e. 15th October 2025

15 Oct, 2025 | 03:26pm • Source: BSE

Certificate under Regulation 74 (5) of SEBI (DP) Regulation, 2018 for the quarter ended on 30th September, 2025.

10 Oct, 2025 | 11:54am • Source: BSE

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 ,inter alia, to consider...

07 Oct, 2025 | 06:08pm • Source: BSE

Please find enclosed herewith Intimation for closure of trading window.

26 Sep, 2025 | 05:14pm • Source: BSE

Intimation of Approval of Extension of time for holding Annual General Meeting (AGM) of the Company for the Financial Year ended on 31st March 2025,...

04 Sep, 2025 | 05:19pm • Source: BSE